2 weeks Ago By Qatar Tribune
Qatar tribune Tribune News Network Doha The National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation (HMC) is at the forefront of cancer treatment in Qatar and the region, setting new standards for excellence in health care. By focusing on personalised, multidisciplinary care and state-of-the-art facilities, NCCCR not only delivers world-class standards of care for patients in Qatar but also attracts patients from across the region. NCCCR’s expert team collaborates to create individualised cancer treatment plans, ensuring optimal outcomes and enhancing the quality of life.
This approach involves experienced oncologists, surgeons, radiologists, nurses and allied health professionals providing comprehensive support throughout the patient’s journey. The hospital employs advanced technology to deliver holistic care that encompasses early detection, diagnosis, treatment, survivorship and palliative care. Timely intervention is critical; over 90 percent of suspected cancer patients at HMC are seen within 48 hours of referral—one of the fastest referral rates globally.
Dr Mohamed Salem Al-Hassan, medical director and CEO of NCCCR and chair Corporate Cancer Services, HMC, commented: “At NCCCR, our patients benefit from advanced facilities equipped with the latest technologies. Our treatment options, including chemotherapy, radiation, immunotherapy, and targeted therapies, are personalized to ensure expert care throughout the journey.” He added, “HMC is a national and regional leader in cancer care, offering unique technologies that set us apart.
Our facilities feature advanced treatment modalities, such as robotic-assisted surgery and innovative imaging techniques, enabling precise interventions that enhance patient outcomes.” NCCCR’s extensive services include Bone Marrow Transplants, where dedicated teams provide personalised care throughout the process, and the Radiation Oncology department, which utilises advanced techniques, such as TrueBeam, ETHOS and CyberKnife, to accurately target tumours while safeguarding healthy tissue. Dr Salha Bujassoum, chair of Medical Oncology, said: “NCCCR offers multidisciplinary personalised care, facilitating services from diagnosis through treatment and prevention in a supportive environment that considers variability in genes, tumour (immune) environment, and lifestyle and morbidities of each person diagnosed with cancer.
Precision Medicine has the potential to tailor medication to each patient’s specific genetic, biochemical, and lifestyle factors. By prioritising the optimisation of tumour response and minimising therapy side effects, patient care and quality of life can be significantly improved.” NCCCR also provides comprehensive genetic counselling and testing to identify hereditary cancer risks, empowering patients to make informed decisions about their care and the importance of mental health during treatment is acknowledged with psychotherapy services that equip patients with coping strategies to address physical and psychological needs.
NCCCR’s advanced capabilities have been crucial in reducing the need for cancer patients in Qatar to travel abroad for further treatment. With comprehensive services and innovative treatment options, patients can effectively manage their conditions within Qatar. Additionally, the exceptional quality and reputation of cancer care at NCCCR attract patients from across the region, including those from GCC countries, who seek treatment at the hospital annually.
Most patients from Western countries diagnosed in Qatar prefer to receive oncology and hematology treatment within HMC rather than returning to their home countries. NCCCR’s continued leadership in cancer care is supported by its commitment to research, education, and collaboration, reinforcing its position as a national and regional leader in oncology services. Copy 04/02/2025 10.
